Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 1
1997 1
1998 2
1999 5
2000 4
2001 4
2002 4
2003 5
2004 4
2005 2
2006 6
2007 5
2008 10
2009 6
2010 5
2011 4
2012 7
2013 7
2014 9
2015 11
2016 10
2017 14
2018 11
2019 7
2020 13
2021 14
2022 14
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Miller Fisher's syndrome.
Teener JW. Teener JW. Semin Neurol. 2012 Nov;32(5):512-6. doi: 10.1055/s-0033-1334470. Epub 2013 May 15. Semin Neurol. 2012. PMID: 23677659 Review.
Miller Fisher's syndrome generally is self-limited and has an excellent prognosis....
Miller Fisher's syndrome generally is self-limited and has an excellent prognosis....
Immune-Mediated Neuropathies.
Gwathmey KG, Smith AG. Gwathmey KG, et al. Neurol Clin. 2020 Aug;38(3):711-735. doi: 10.1016/j.ncl.2020.03.008. Epub 2020 Jun 11. Neurol Clin. 2020. PMID: 32703478 Review.
The immune-mediated neuropathies are a broad category of diseases differentiated by time course, affected nerve fibers, and disease associations. This article spans the common, well-defined inflammatory demyelinating polyradiculoneuropathies (Guillain-Barre syndrome and ch …
The immune-mediated neuropathies are a broad category of diseases differentiated by time course, affected nerve fibers, and disease a …
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, Blomkwist-Markens PH, Cornblath DR, Goedee HS, Harbo T, Jacobs BC, Kusunoki S, Lehmann HC, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Umapathi T, Topaloglu HA, Willison HJ. van Doorn PA, et al. Eur J Neurol. 2023 Dec;30(12):3646-3674. doi: 10.1111/ene.16073. Epub 2023 Oct 10. Eur J Neurol. 2023. PMID: 37814552
To develop an evidence-based guideline for the diagnosis and treatment of GBS, using Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology a Task Force (TF) of the European Academy of Neurology (EAN) and the Peripheral Nerve Society (PNS) construc …
To develop an evidence-based guideline for the diagnosis and treatment of GBS, using Grading of Recommendations, Assessment, Development and …
Guillain-Barré syndrome mimics.
Tham SL, Prasad K, Umapathi T. Tham SL, et al. Brain Behav. 2018 Apr 10;8(5):e00960. doi: 10.1002/brb3.960. eCollection 2018 May. Brain Behav. 2018. PMID: 29761013 Free PMC article.
Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS).
van Doorn PA. van Doorn PA. Presse Med. 2013 Jun;42(6 Pt 2):e193-201. doi: 10.1016/j.lpm.2013.02.328. Epub 2013 Apr 28. Presse Med. 2013. PMID: 23628447 Review.
Pain can also be very confusing in making the diagnosis, especially when it precedes the onset of weakness. Advances in prognostic modelling resulted in the development of a simple prognostic scale that predicts the chance for artificial ventilation, already …
Pain can also be very confusing in making the diagnosis, especially when it precedes the onset of weakness. Advances in prognostic mo …
Regional variation of Guillain-Barré syndrome.
Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium. Doets AY, et al. Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232. Brain. 2018. PMID: 30247567 Free article.
Comparative studies are required to identify factors determining disease susceptibility, variation and prognosis, and to improve diagnostic criteria. The International Guillain-Barre Syndrome Outcome Study is a prospective, observational cohort study including all patients …
Comparative studies are required to identify factors determining disease susceptibility, variation and prognosis, and to improve diag …
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, Blomkwist-Markens PH, Cornblath DR, Goedee HS, Harbo T, Jacobs BC, Kusunoki S, Lehmann HC, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Umapathi T, Topaloglu HA, Willison HJ. van Doorn PA, et al. J Peripher Nerv Syst. 2023 Dec;28(4):535-563. doi: 10.1111/jns.12594. Epub 2023 Oct 10. J Peripher Nerv Syst. 2023. PMID: 37814551 Review.
To develop an evidence-based guideline for the diagnosis and treatment of GBS, using Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, a Task Force (TF) of the European Academy of Neurology (EAN) and the Peripheral Nerve Society (PNS) constru …
To develop an evidence-based guideline for the diagnosis and treatment of GBS, using Grading of Recommendations, Assessment, Development and …
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Abu-Rumeileh S, et al. J Neurol. 2021 Apr;268(4):1133-1170. doi: 10.1007/s00415-020-10124-x. Epub 2020 Aug 25. J Neurol. 2021. PMID: 32840686 Free PMC article.
Cerebrospinal fluid (CSF) albuminocytological dissociation was present in around 71% cases, and CSF SARS-CoV-2 RNA was absent in all tested cases. More than 70% of patients showed a good prognosis, mostly after treatment with intravenous immunoglobulin. ...
Cerebrospinal fluid (CSF) albuminocytological dissociation was present in around 71% cases, and CSF SARS-CoV-2 RNA was absent in all tested …
Ataxia.
Winchester S, Singh PK, Mikati MA. Winchester S, et al. Handb Clin Neurol. 2013;112:1213-7. doi: 10.1016/B978-0-444-52910-7.00043-X. Handb Clin Neurol. 2013. PMID: 23622331 Review.
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN, Yoo HJ. Harapan BN, et al. J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23. J Neurol. 2021. PMID: 33486564 Free PMC article. Review.
Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further clarify and assess the link between neurological complications and the clinical outcome of patients with COVID-19. ...
Future studies that examine the impact of neurological symptoms and manifestations on the course of the disease are needed to further …
177 results